MFN agreements spanning 26 drugmakers are reshaping revenue assumptions for Pfizer, Amgen, and the insurers many income...
The HORIZON trial failure wipes a defined economic stake from Ionis's model and raises a harder question...
A $4.4 billion bet on EPC Power redefines what Flex can own in AI power.
Running is growing fast, China is still a problem, and Q1 fiscal 2027 earnings are the first...
Payrolls beat expectations, but the Fed still waits on next week’s CPI.
Waller’s hold signal erased a week of hike fears in one session, and the winners show where...
Four targets from $136 to $160 in 48 hours. With HOOD at $113.80 and the NFL here,...
Agentforce ARR topped $1.5 billion, up 240% year over year, and the company raised full-year guidance. Dreamforce...
Roughly $28 trillion tracks the S&P 500. The better question is whether Alnylam deserves a spot in...
Brent near $95 and XOP at a 52-week high look great until a single ceasefire headline yanks...